دورية أكاديمية

Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons.

التفاصيل البيبلوغرافية
العنوان: Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons.
المؤلفون: Seguí, Inés Gómez, Mingot Castellano, María Eva, Izquierdo, Cristina Pascual, de la Rubia, Javier
المصدر: Expert Review of Hematology; Jan-Mar2024, Vol. 17 Issue 1-3, p9-25, 17p
قاعدة البيانات: Complementary Index
الوصف
تدمد:17474086
DOI:10.1080/17474086.2024.2318347